Logo image of NEPH

NEPHROS INC (NEPH) Stock Fundamental Analysis

NASDAQ:NEPH - Nasdaq - US6406714005 - Common Stock - Currency: USD

3.645  +0.06 (+1.82%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NEPH. NEPH was compared to 127 industry peers in the Machinery industry. NEPH has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, NEPH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year NEPH was profitable.
In the past year NEPH had a positive cash flow from operations.
In the past 5 years NEPH reported 4 times negative net income.
In the past 5 years NEPH reported 4 times negative operating cash flow.
NEPH Yearly Net Income VS EBIT VS OCF VS FCFNEPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of NEPH (6.80%) is better than 65.35% of its industry peers.
NEPH has a Return On Equity of 8.62%. This is comparable to the rest of the industry: NEPH outperforms 48.03% of its industry peers.
NEPH has a Return On Invested Capital (6.26%) which is in line with its industry peers.
Industry RankSector Rank
ROA 6.8%
ROE 8.62%
ROIC 6.26%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
NEPH Yearly ROA, ROE, ROICNEPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

NEPH has a Profit Margin of 5.16%. This is comparable to the rest of the industry: NEPH outperforms 47.24% of its industry peers.
NEPH has a Operating Margin of 4.98%. This is in the lower half of the industry: NEPH underperforms 62.20% of its industry peers.
The Gross Margin of NEPH (62.45%) is better than 97.64% of its industry peers.
In the last couple of years the Gross Margin of NEPH has remained more or less at the same level.
Industry RankSector Rank
OM 4.98%
PM (TTM) 5.16%
GM 62.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
NEPH Yearly Profit, Operating, Gross MarginsNEPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NEPH is destroying value.
The number of shares outstanding for NEPH remains at a similar level compared to 1 year ago.
NEPH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NEPH is higher compared to a year ago.
NEPH Yearly Shares OutstandingNEPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NEPH Yearly Total Debt VS Total AssetsNEPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

NEPH has an Altman-Z score of -5.47. This is a bad value and indicates that NEPH is not financially healthy and even has some risk of bankruptcy.
NEPH has a Altman-Z score of -5.47. This is amonst the worse of the industry: NEPH underperforms 91.34% of its industry peers.
NEPH has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
NEPH has a better Debt to FCF ratio (0.05) than 92.13% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NEPH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, NEPH belongs to the top of the industry, outperforming 83.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z -5.47
ROIC/WACC0.63
WACC9.88%
NEPH Yearly LT Debt VS Equity VS FCFNEPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

NEPH has a Current Ratio of 5.92. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.92, NEPH belongs to the best of the industry, outperforming 94.49% of the companies in the same industry.
NEPH has a Quick Ratio of 4.64. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
NEPH has a better Quick ratio (4.64) than 94.49% of its industry peers.
Industry RankSector Rank
Current Ratio 5.92
Quick Ratio 4.64
NEPH Yearly Current Assets VS Current LiabilitesNEPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 150.00% over the past year.
The Revenue has grown by 10.32% in the past year. This is quite good.
Measured over the past years, NEPH shows a small growth in Revenue. The Revenue has been growing by 6.51% on average per year.
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%350%
Revenue 1Y (TTM)10.32%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%38.47%

3.2 Future

NEPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 5422130327.01% yearly.
NEPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.70% yearly.
EPS Next Y146997491837372900%
EPS Next 2Y5422130327.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.25%
Revenue Next 2Y14.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NEPH Yearly Revenue VS EstimatesNEPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
NEPH Yearly EPS VS EstimatesNEPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

NEPH is valuated quite expensively with a Price/Earnings ratio of 52.07.
NEPH's Price/Earnings ratio is a bit more expensive when compared to the industry. NEPH is more expensive than 69.29% of the companies in the same industry.
NEPH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
NEPH is valuated quite expensively with a Price/Forward Earnings ratio of 357.35.
70.87% of the companies in the same industry are cheaper than NEPH, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of NEPH to the average of the S&P500 Index (36.44), we can say NEPH is valued expensively.
Industry RankSector Rank
PE 52.07
Fwd PE 357.35
NEPH Price Earnings VS Forward Price EarningsNEPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

NEPH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NEPH is more expensive than 74.02% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NEPH is valued a bit more expensive than the industry average as 68.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 86.44
EV/EBITDA 37.79
NEPH Per share dataNEPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NEPH's earnings are expected to grow with 5422130327.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y5422130327.01%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NEPH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEPHROS INC

NASDAQ:NEPH (7/18/2025, 8:00:01 PM)

3.645

+0.06 (+1.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06
Inst Owners44.01%
Inst Owner Change0%
Ins Owners10.74%
Ins Owner Change0%
Market Cap38.64M
Analysts82.5
Price Target4.85 (33.06%)
Short Float %0.04%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)688.24%
Min EPS beat(2)296.08%
Max EPS beat(2)1080.39%
EPS beat(4)3
Avg EPS beat(4)369.61%
Min EPS beat(4)-96.08%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)186.58%
EPS beat(12)7
Avg EPS beat(12)103.11%
EPS beat(16)8
Avg EPS beat(16)71.4%
Revenue beat(2)2
Avg Revenue beat(2)18.61%
Min Revenue beat(2)6.29%
Max Revenue beat(2)30.93%
Revenue beat(4)2
Avg Revenue beat(4)4.59%
Min Revenue beat(4)-17.42%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)1.96%
Revenue beat(12)5
Avg Revenue beat(12)-0.04%
Revenue beat(16)5
Avg Revenue beat(16)-3.1%
PT rev (1m)0%
PT rev (3m)5.56%
EPS NQ rev (1m)-150%
EPS NQ rev (3m)-600%
EPS NY rev (1m)0%
EPS NY rev (3m)-75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.17%
Valuation
Industry RankSector Rank
PE 52.07
Fwd PE 357.35
P/S 2.49
P/FCF 86.44
P/OCF 76.97
P/B 4.16
P/tB 4.84
EV/EBITDA 37.79
EPS(TTM)0.07
EY1.92%
EPS(NY)0.01
Fwd EY0.28%
FCF(TTM)0.04
FCFY1.16%
OCF(TTM)0.05
OCFY1.3%
SpS1.46
BVpS0.88
TBVpS0.75
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.8%
ROE 8.62%
ROCE 7.52%
ROIC 6.26%
ROICexc 10.39%
ROICexgc 13.16%
OM 4.98%
PM (TTM) 5.16%
GM 62.45%
FCFM 2.88%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score6
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.02
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 772
Cash Conversion 54.86%
Profit Quality 55.81%
Current Ratio 5.92
Quick Ratio 4.64
Altman-Z -5.47
F-Score6
WACC9.88%
ROIC/WACC0.63
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%350%
EPS Next Y146997491837372900%
EPS Next 2Y5422130327.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.32%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%38.47%
Revenue Next Year17.25%
Revenue Next 2Y14.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y151.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y135.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.65%
OCF growth 3YN/A
OCF growth 5YN/A